EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for NXGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -0.4033
March 31, 2026 -0.113
December 31, 2025 -0.1191
September 30, 2025 -0.0819
June 30, 2025 -0.0869
March 31, 2025 -0.0931
December 31, 2024 -0.1164
September 30, 2024 -0.1055
June 30, 2024 -0.1415
March 31, 2024 -0.1426
December 31, 2023 -0.1912
September 30, 2023 -0.0962
June 30, 2023 -0.1227
March 31, 2023 -0.1445
December 31, 2022 -0.1162
September 30, 2022 -0.2202
Date Value
June 30, 2022 -0.1857
March 31, 2022 -0.3295
December 31, 2021 -0.2941
September 30, 2021 -0.011
June 30, 2021 -0.008
March 31, 2021 -0.007
December 31, 2020 -0.0065
September 30, 2020 -0.0052
June 30, 2020 -0.0051
March 31, 2020 -0.0049
December 31, 2019 -0.0054
September 30, 2019 0.0129
June 30, 2019 -0.0103
March 31, 2019 -0.0059
December 31, 2018 -0.0115
September 30, 2018 -0.1506

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 0.5324
Align Technology, Inc. 1.514
AngioDynamics, Inc. -0.2735
Accuray, Inc. -0.0154
Alphatec Holdings, Inc. -0.1647